InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Doyle Ramona, Directeur Médical. Insider active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 9 filings have been recorded. History available since 3 January 2022. The latest transaction was disclosed on 16 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
832 shares@ US$5.670.0002% mcap1.5% of flowClass A Common StockSEC:0001209191-22-030255:0
9,072 shares@ US$2.480.0009% mcap6.7% of flowClass A Common StockSEC:0001209191-22-022310:0
15,625 shares@ US$2.480.0016% mcap11.4% of flowClass A Common StockSEC:0001209191-22-014405:0
38,499 shares0Class A Common StockSEC:0001209191-22-007915:0
38,499 shares0Class A Common StockSEC:0001209191-22-007915
15,625 shares@ US$2.4828.4% of flowClass A Common StockSEC:0001209191-22-006598
15,625 shares@ US$2.480.0016% mcap11.4% of flowClass A Common StockSEC:0001209191-22-006598:0
40,322 shares@ US$2.4771.6% of flowClass A Common StockSEC:0001209191-22-002062
40,322 shares@ US$2.470.0041% mcap28.8% of flowClass A Common StockSEC:0001209191-22-002062:0
9 of 9 declarations
About Doyle Ramona
Ramona Doyle is the Chief Medical Officer at RECURSION PHARMACEUTICALS, INC. She is responsible for the medical direction of the company, overseeing clinical and research activities. Ramona plays a key role in developing strategies to create innovative treatments and ensure patient safety. Her medical expertise is essential in guiding the company's strategic decisions and research initiatives.
